RAD50 and acute myeloid leukemia: Our findings provided evidence that AC021683.2 functions as a lncRNA by regulating BCLAF1 in AML, and revealed that targeting the AC021683.2/BACLAF1/RAD50 axis provides potential strategy for the treatment of resistance to Ara-C in AML.